All Stories

  1. Tg.rasH2 Mice and not CByB6F1 Mice Should Be Used for 28-Day Dose Range Finding Studies Prior to 26-Week Tg.rasH2 Carcinogenicity Studies

    Article • International Journal of Toxicology, May 2017, SAGE Publications

    Dr Madhav Paranjpe

  2. Exudative Inflammatory Lesions in the Nasal Cavities of the 26-Week Tg.rasH2 Mice Oral Gavage Carcinogenicity Studies

    Article • International Journal of Toxicology, December 2016, SAGE Publications

    Dr Madhav Paranjpe

  3. Vascular proliferation on serosa of uterus in Tg.rasH2 mice can progress to hemangiosarcoma.

    Article • International Journal of Toxicology, July 2016, SAGE Publications

    Dr Madhav Paranjpe, Dr Madhav Paranjpe

  4. Renal Tumors in 26-Week Tg.Rash2 Mice Carcinogenicity Studies

    Article • Toxicologic Pathology, February 2016, SAGE Publications

    Dr Madhav Paranjpe, Dr Madhav Paranjpe

  5. Recommendations to eliminate high doses set at MTD in Tg.rasH2 carcinogenicity studies.

    Article • Toxicologic Pathology, November 2015, SAGE Publications

    Dr Madhav Paranjpe, Dr Madhav Paranjpe

  6. Duodenal crypt health following exposure to Cr(VI): Micronucleus scoring, γ-H2AX immunostaining, and synchrotron X-ray fluorescence microscopy

    Article • Mutation Research/Genetic Toxicology and Environmental Mutagenesis, August 2015, Elsevier

    Dr Madhav Paranjpe

  7. Carcinogenicity assessment of the pan-caspase inhibitor, emricasan, in Tg.rasH2 mice

    Article • Regulatory Toxicology and Pharmacology, July 2015, Elsevier

    Dr Madhav Paranjpe

  8. Combination comet/micronucleus assay validation performed by BioReliance under the JaCVAM initiative

    Article • Mutation Research/Genetic Toxicology and Environmental Mutagenesis, July 2015, Elsevier

    Dr Madhav Paranjpe

  9. Regulatory Forum Opinion Piece*

    Article • Toxicologic Pathology, November 2014, SAGE Publications

    Dr Madhav Paranjpe

  10. Trend Analysis of Body Weight Parameters, Mortality, and Incidence of Spontaneous Tumors in Tg.rasH2 Mice

    Article • International Journal of Toxicology, September 2014, SAGE Publications

    Dr Madhav Paranjpe

  11. Relationship of Body Weight Parameters with the Incidence of Common Spontaneous Tumors in Tg.rasH2 Mice

    Article • Toxicologic Pathology, November 2013, SAGE Publications

    Dr Madhav Paranjpe

  12. The 26-Week Tg.Rash2 Mice Carcinogenicity Studies

    Article • Toxicologic Pathology, August 2013, SAGE Publications

    Dr Madhav Paranjpe

  13. Incidence of Spontaneous Non-Neoplastic Lesions in Transgenic CBYB6F1-Tg(HRAS)2Jic Mice

    Article • Toxicologic Pathology, February 2013, SAGE Publications

    Dr Madhav Paranjpe

  14. Historical Control Data of Spontaneous Tumors in Transgenic CByB6F1-Tg(HRAS)2Jic (Tg.rasH2) Mice

    Article • International Journal of Toxicology, January 2013, SAGE Publications

    Dr Madhav Paranjpe

  15. Reduction in the Number of Animals and the Evaluation Period for the Positive Control Group in Tg.rasH2 Short-Term Carcinogenicity Studies

    Article • International Journal of Toxicology, September 2012, SAGE Publications

    Dr Madhav Paranjpe

  16. Genotoxic assessment and toxicity evaluation of peginesatide in CByB6F1 hybrid mice

    Article • Drug and Chemical Toxicology, June 2011, Taylor & Francis

    Dr Madhav Paranjpe

  17. Immunohistochemical and Clinical Evaluation of p53 in Canine Cutaneous Mast Cell Tumors

    Article • Veterinary Pathology, January 2000, SAGE Publications

    Dr Madhav Paranjpe

  18. Fluorosis in a Wild Cotton Rat (Sigmodon hispidus) Population Inhabiting a Petrochemical Waste Site

    Article • Toxicologic Pathology, November 1994, SAGE Publications

    Dr Madhav Paranjpe

  19. Spontaneous Altered Hepatocellular Foci (AHF) in Captive Aged Male Cotton Rats (Sigmodon hispidus)

    Article • Journal of Comparative Pathology, November 1993, Elsevier

    Dr Madhav Paranjpe